Paper39210306
Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior.
Gu X and 3 others. BMC Cancer, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior. Papers, record 39210306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39210306
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| RNA, Long Noncoding | Major topic |
| Humans | |
| Prognosis | |
| Male | |
| Biomarkers, Tumor | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Middle Aged | |
| Cell Proliferation | |
| Cell Line, Tumor | |
| Computational Biology |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27102039 | Cystinosis: a review. | Orphanet J Rare Dis | 2016 | https://conductscience.org/library/papers/27102039 | PubMed |
| 2 | 12189052 | Biological regulation through protein disulfide bond cleavage. | Redox Rep | 2002 | https://conductscience.org/library/papers/12189052 | PubMed |
| 3 | 37152941 | Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37152941 | PubMed |
| 4 | 32481346 | Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32481346 | PubMed |
| 5 | 35624210 | Epigenetic regulation of T cell exhaustion. | Nat Immunol | 2022 | https://conductscience.org/library/papers/35624210 | PubMed |
| 6 | 36965032 | Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacity. | Mol Oncol | 2023 | https://conductscience.org/library/papers/36965032 | PubMed |
| 7 | 36747082 | Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36747082 | PubMed |
| 8 | 29075797 | [Early stage liver cancer : Hepatocellular carcinoma]. | Chirurg | 2018 | https://conductscience.org/library/papers/29075797 | PubMed |
| 9 | 35068855 | Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/35068855 | PubMed |
| 10 | 32285278 | Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. | Ann Surg Oncol | 2020 | https://conductscience.org/library/papers/32285278 | PubMed |
| 11 | 33391418 | LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. | J Cancer | 2021 | https://conductscience.org/library/papers/33391418 | PubMed |
| 12 | 37101248 | Disulfidptosis: a new target for metabolic cancer therapy. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37101248 | PubMed |
| 13 | 35138470 | SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition. | Biochem Genet | 2022 | https://conductscience.org/library/papers/35138470 | PubMed |
| 14 | 36695827 | Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36695827 | PubMed |
| 15 | 34903711 | HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34903711 | PubMed |
| 16 | 36973424 | E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. | Cancer Gene Ther | 2023 | https://conductscience.org/library/papers/36973424 | PubMed |
| 17 | 35634426 | Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study. | Liver Cancer | 2022 | https://conductscience.org/library/papers/35634426 | PubMed |
| 18 | 25685869 | Cystinuria: current concepts and future directions. | Clin Nephrol | 2015 | https://conductscience.org/library/papers/25685869 | PubMed |
| 19 | 33000222 | Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. | Int J Mol Med | 2020 | https://conductscience.org/library/papers/33000222 | PubMed |
| 20 | 37575978 | Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature. | Genet Res (Camb) | 2023 | https://conductscience.org/library/papers/37575978 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40892177 | Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40892177 | PubMed |
| 40790550 | Elucidating the role of AC026412.3 in hepatocellular carcinoma: a prognostic disulfidptosis-related LncRNAs model perspective. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40790550 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| KDM4A | 9682 | PubTator's text mining | https://conductscience.org/library/genes/9682 | NCBI Gene |
| MKLN1 | 4289 | PubTator's text mining | https://conductscience.org/library/genes/4289 | NCBI Gene |
| TMCC1 | 23023 | PubTator's text mining | https://conductscience.org/library/genes/23023 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39210306
GET https://conductscience.org/api/papers/v1/39210306/references?page=2